Export certificate backgrounder
This article was originally published in The Gray Sheet
Executive SummaryFDA issues 1July export certificate guidance addressing general agency-wide policies for certificates, including CDRH "non-clinical research use only certificates," "certificates to foreign government" and "certificates of exportability"...
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.
Keeping Track: Approvals For Tazverik And Tepezza, Priority Reviews For Belantamab Mafodotin And Lynparza
The latest drug development news and highlights from our US FDA Performance Tracker.
Accelerated approval in epithelial sarcoma may de-risk the firm’s goals for approval of Tazverik in follicular lymphoma and other larger indications.